ELUTIA INC (ELUT) Stock Fundamental Analysis

NASDAQ:ELUT • US05479K1060

1.15 USD
+0.1 (+9.52%)
Last: Feb 17, 2026, 08:11 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

ELUT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. ELUT may be in some trouble as it scores bad on both profitability and health. ELUT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ELUT has reported negative net income.
  • In the past year ELUT has reported a negative cash flow from operations.
  • ELUT had negative earnings in each of the past 5 years.
  • In the past 5 years ELUT always reported negative operating cash flow.
ELUT Yearly Net Income VS EBIT VS OCF VS FCFELUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • With a Return On Assets value of -90.02%, ELUT is not doing good in the industry: 72.17% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -90.02%
ROE N/A
ROIC N/A
ROA(3y)-94.61%
ROA(5y)-70.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ELUT Yearly ROA, ROE, ROICELUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 1K -1K -2K -3K -4K

1.3 Margins

  • With a decent Gross Margin value of 45.97%, ELUT is doing good in the industry, outperforming 74.66% of the companies in the same industry.
  • ELUT's Gross Margin has been stable in the last couple of years.
  • ELUT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.05%
GM growth 5Y-0.95%
ELUT Yearly Profit, Operating, Gross MarginsELUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • ELUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ELUT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ELUT has more shares outstanding
  • Compared to 1 year ago, ELUT has a worse debt to assets ratio.
ELUT Yearly Shares OutstandingELUT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ELUT Yearly Total Debt VS Total AssetsELUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • ELUT has an Altman-Z score of -14.01. This is a bad value and indicates that ELUT is not financially healthy and even has some risk of bankruptcy.
  • ELUT has a worse Altman-Z score (-14.01) than 78.50% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.01
ROIC/WACCN/A
WACC12.61%
ELUT Yearly LT Debt VS Equity VS FCFELUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

  • ELUT has a Current Ratio of 0.44. This is a bad value and indicates that ELUT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.44, ELUT is not doing good in the industry: 90.60% of the companies in the same industry are doing better.
  • ELUT has a Quick Ratio of 0.44. This is a bad value and indicates that ELUT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.40, ELUT is doing worse than 90.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.4
ELUT Yearly Current Assets VS Current LiabilitesELUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 73.95% over the past year.
  • The Revenue for ELUT has decreased by -33.02% in the past year. This is quite bad
  • ELUT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.69% yearly.
EPS 1Y (TTM)73.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.73%
Revenue 1Y (TTM)-33.02%
Revenue growth 3Y-19.88%
Revenue growth 5Y-10.69%
Sales Q2Q%-43.89%

3.2 Future

  • Based on estimates for the next years, ELUT will show a very strong growth in Earnings Per Share. The EPS will grow by 22.61% on average per year.
  • The Revenue is expected to decrease by -8.34% on average over the next years.
EPS Next Y81.83%
EPS Next 2Y33.85%
EPS Next 3Y22.61%
EPS Next 5YN/A
Revenue Next Year-23.39%
Revenue Next 2Y-21.45%
Revenue Next 3Y-8.34%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ELUT Yearly Revenue VS EstimatesELUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ELUT Yearly EPS VS EstimatesELUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ELUT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ELUT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ELUT Price Earnings VS Forward Price EarningsELUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ELUT Per share dataELUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ELUT's earnings are expected to grow with 22.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.85%
EPS Next 3Y22.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ELUT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ELUTIA INC

NASDAQ:ELUT (2/17/2026, 8:11:38 PM)

1.15

+0.1 (+9.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-09
Earnings (Next)03-04
Inst Owners39.76%
Inst Owner ChangeN/A
Ins Owners2.92%
Ins Owner Change12.2%
Market Cap49.10M
Revenue(TTM)21.08M
Net Income(TTM)-26.47M
Analysts82.5
Price Target3.57 (210.43%)
Short Float %0.5%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.22%
Min EPS beat(2)-32.64%
Max EPS beat(2)43.07%
EPS beat(4)2
Avg EPS beat(4)15.16%
Min EPS beat(4)-32.64%
Max EPS beat(4)52.18%
EPS beat(8)3
Avg EPS beat(8)-32.92%
EPS beat(12)5
Avg EPS beat(12)-27.63%
EPS beat(16)6
Avg EPS beat(16)-23.29%
Revenue beat(2)0
Avg Revenue beat(2)-28.63%
Min Revenue beat(2)-51.01%
Max Revenue beat(2)-6.26%
Revenue beat(4)0
Avg Revenue beat(4)-19.38%
Min Revenue beat(4)-51.01%
Max Revenue beat(4)-6.26%
Revenue beat(8)1
Avg Revenue beat(8)-12.66%
Revenue beat(12)2
Avg Revenue beat(12)-9.2%
Revenue beat(16)4
Avg Revenue beat(16)-6.52%
PT rev (1m)0%
PT rev (3m)-12.5%
EPS NQ rev (1m)4.17%
EPS NQ rev (3m)20.69%
EPS NY rev (1m)1.12%
EPS NY rev (3m)29.6%
Revenue NQ rev (1m)9.68%
Revenue NQ rev (3m)-37.04%
Revenue NY rev (1m)1.6%
Revenue NY rev (3m)-21.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.33
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0.49
BVpS-1.03
TBVpS-1.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -90.02%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.97%
FCFM N/A
ROA(3y)-94.61%
ROA(5y)-70.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.05%
GM growth 5Y-0.95%
F-Score3
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.32%
Cap/Sales 5.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.4
Altman-Z -14.01
F-Score3
WACC12.61%
ROIC/WACCN/A
Cap/Depr(3y)14.22%
Cap/Depr(5y)13.83%
Cap/Sales(3y)1.73%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.73%
EPS Next Y81.83%
EPS Next 2Y33.85%
EPS Next 3Y22.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-33.02%
Revenue growth 3Y-19.88%
Revenue growth 5Y-10.69%
Sales Q2Q%-43.89%
Revenue Next Year-23.39%
Revenue Next 2Y-21.45%
Revenue Next 3Y-8.34%
Revenue Next 5YN/A
EBIT growth 1Y10.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.24%
OCF growth 3YN/A
OCF growth 5YN/A

ELUTIA INC / ELUT FAQ

Can you provide the ChartMill fundamental rating for ELUTIA INC?

ChartMill assigns a fundamental rating of 1 / 10 to ELUT.


Can you provide the valuation status for ELUTIA INC?

ChartMill assigns a valuation rating of 1 / 10 to ELUTIA INC (ELUT). This can be considered as Overvalued.


Can you provide the profitability details for ELUTIA INC?

ELUTIA INC (ELUT) has a profitability rating of 1 / 10.


How financially healthy is ELUTIA INC?

The financial health rating of ELUTIA INC (ELUT) is 0 / 10.